Comments
Loading...

ImmuCell

ICCCNASDAQ
Logo brought to you by Benzinga Data
$4.41
-0.17-3.71%
At close: -
$4.19
-0.22-4.99%
After Hours: Dec 20, 4:34 PM EDT

ImmuCell (NASDAQ:ICCC) Stock, Earnings Estimates, EPS, And Revenue

ImmuCell reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 13
EPS
$-0.090
Quarterly Revenue
$6M
Annual Revenue
(as of Sep 30)
$23.8M

Analyze the earnings history of ImmuCell using advanced sorting and filters.

Data brought to you by Benzinga APIs

ImmuCell (ICCC) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Mar 20212021-05-13$-0.06$0.05-220.0 %
Sep 20202020-11-12$-0.04$-0.0850.0 %
Jun 20202020-08-12$-0.11$-0.10-10.0 %

ImmuCell (ICCC) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-08-13$5.47M$3.26M67.9 %
Sep 20222022-11-21$4.80M$5.40M-11.2 %
Mar 20222022-05-12$6.00M$5.40M11.1 %
Dec 20212022-02-22$5.44M$5.40M0.81 %

FAQ

Q

When is ImmuCell (NASDAQ:ICCC) reporting earnings?

A

ImmuCell (ICCC) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for ImmuCell (NASDAQ:ICCC)?

A

The Actual EPS was $-0.09, which missed the estimate of $0.00.

Q

What were ImmuCell’s (NASDAQ:ICCC) revenues?

A

The Actual Revenue was $6M, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch